CCNB1 and CDC2 play important roles in the proliferation of Glioma cells [56], the expression of PTTG1 is correlated with poor prognosis in Glioma patients [57], and aberrant splicing of CDKN3 increases proliferation and migration in Glioma cells [58]. Here, CCNB1 is linked to central nervous system cancer.